Future potential of vaccines
New vaccines and vaccine technology are a constant source of hope.
Vaccine innovation offers hope for the future
The biopharmaceutical industry is developing new vaccines to prevent diseases like HIV, RSV and Dengue. We’re making vaccines easier to transport, store, and administer. We’re also finding new ways to speed up production and make more vaccines when they are needed. Vaccines offer the chance to tackle global health threats, such as antimicrobial resistance. This is a constant source of hope for the future.
Developing and improving vaccines
There are hundreds of new vaccines being developed to protect against a number of diseases and pathogens which lack effective vaccines. The industry is also working to improve existing vaccines so that they work even better and protect for longer. Achieving new breakthroughs can take decades but we’re determined to help save lives and prevent hospitalizations.
Juliette explains how new innovations to protect young children against the respiratory virus RSV could help over 3 million children who are hospitalised due to this virus every year .Read Juliette's story
Vaccines Research & Development
Jamila explains why, even though a vaccine for HIV continues to elude researchers, she’s confident new technologies and ongoing innovation mean it’s within reach.Read Jamila's story
Tackling the world’s biggest health threats
Our world is facing major threats to public health. But vaccines can help us to overcome these challenges. By helping to prevent bacterial infections, vaccines can help to slow the development of drug-resistant superbugs. And as warmer temperatures due to climate change bring diseases to new regions, new vaccines could help to keep people safe from serious illness.
Research Team Leader
Anish explains how vaccines can help to protect modern medicine by helping to slow the spread of antimicrobial resistance and prevent life-threatening infections.Read Anish's story
Vaccine Clinical Development
Shibadas explains how climate change is putting more people around the world at risk of Dengue, and how new vaccines could help to protect them.Read Shibadas's story
Preparing for future outbreaks and pandemics
As the COVID-19 pandemic has shown, the better prepared we are, the faster we can respond when outbreaks happen. That’s why the biopharmaceutical industry is developing new vaccines for pathogens with pandemic potential, like influenza. And implementing new manufacturing approaches so we can speed up and scale up development when the next emergency strikes.
Ethan explains how innovation in vaccine technology could lead to next-generation flu vaccines that enable us to get ahead of this fast-mutating virus.Read Ethan's story
Pierre-Damien explains how innovative new developments in vaccine manufacturing could make it easier to switch to producing new vaccines in response to future pandemics.Read Pierre-Damien's story
References and further links
- How much of an impact do vaccines really have? (Gavi 2021)
- Medicines in development for vaccines (PhRMA 2020)
- Biopharmaceutical industry collaborates on the implementation of the G7 100 Days Mission to improve readiness for future pandemics (IFPMA 2021)
- The race to make vaccines for a dangerous respiratory virus (Nature 2021)
Tomorrow’s vaccines rely on continued investment and dedication
The development of new and improved vaccines is made possible by dedication to science, ongoing innovation, and scientific ingenuity in universities, research institutions, biotechs and research-based biopharmaceutical companies around the world.
Sustained investment in vaccine innovation and continued collaboration with research and development partners helps protect us all against health threats. It also prevents the return of infectious diseases that we have mostly controlled or eliminated and it helps to ensure we are prepared when new threats happen.